Drugs / ODM-101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01766258 | May 2011 → Aug 2012 | Parkinson disease | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ODM-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01766258 ↗ |